PTSM: Pharmaceutical Technology Sourcing and Management
Consisting of a needle hub and a needle shield, the new syringe closure system is partly produced by means of a two-component injection molding process of polypropylene and thermoplastic elastomer.
Vetter has launched a new closure system for prefilled syringes, Vetter-Ject. Developed with usability in mind, the system comes with tamper-evident features and can be used with highly sensitive compounds, such as biologics. Consisting of a needle hub and a needle shield, the new syringe closure system is partly produced by means of a two-component injection molding process of polypropylene and thermoplastic elastomer.
There is an increasing number of drug products consisting of sensitive and complex molecules. Such drugs require an injection system that is flexible, safe, and easy to handle. Vetter has developed Vetter-Ject to meet this demand.
The baked-in siliconization process for the glass barrel uses less silicone oil, making the system suitable for silicone-sensitive formulations. According to Vetter, the silicone content of the syringe can also be customized to specific requirements. The amount of silicone used, as well as the related particle load, can be reduced by up to 80% compared with the standard siliconization process applied to conventional syringe systems.
Vetter-Ject can be used with a wide range of primary packaging options, such as different stoppers and glass barrels. Vetter also provides complete sterile fill and finish services and offers as part of its packaging service the assembly and final packaging of Vetter-Ject syringe system-from trays and plunger rod assembly, to auto-injector assembly and final packaging.
Source: Vetter
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.